annb0t
Top 20
European pharmaceutical company offers its investigational medicinal product to a wide range of specialist medical practitioners in the United Kingdom
Epidiolex's Success Highlights Potential for MGC Pharma's CannEpil®
The recent success of Epidiolex, a CBD-based epilepsy treatment that generated $296 million in sales in 2019, highlights the potential for MGC Pharma's CannEpil® in the UK market. This underlines the potential of CannEpil®, an investigational medicinal product for patie...
>>> Read more: MGC Pharma's CannEpil® Now Accessible to UK Patients on Named Patient Request Basis
Epidiolex's Success Highlights Potential for MGC Pharma's CannEpil®
The recent success of Epidiolex, a CBD-based epilepsy treatment that generated $296 million in sales in 2019, highlights the potential for MGC Pharma's CannEpil® in the UK market. This underlines the potential of CannEpil®, an investigational medicinal product for patie...
>>> Read more: MGC Pharma's CannEpil® Now Accessible to UK Patients on Named Patient Request Basis
